Etrolizumab in moderate-to-severe ulcerative colitis

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

no abstract available
Original languageEnglish
Pages (from-to)285-286
Number of pages2
JournalTHE LANCET
Volume384
DOIs
Publication statusPublished - 2014

Keywords

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Colitis, Ulcerative
  • Female
  • Humans
  • Male

Fingerprint

Dive into the research topics of 'Etrolizumab in moderate-to-severe ulcerative colitis'. Together they form a unique fingerprint.

Cite this